Literature DB >> 9354691

Exclusion of three candidate genes as determinants of congenital dyserythropoietic anemia type II (CDA-II).

A Iolascon1, E Miraglia del Giudice, S Perrotta, M Granatiero, L Zelante, P Gasparini.   

Abstract

Congenital dyserythropoietic anemia type II (CDA-II) is the most common form of inherited dyserythropoiesis. Previous studies have shown that the anion transporter (band 3) is narrower and it migrates faster on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE); this aspect was related to insufficient glycosylation. Biochemical data support the hypothesis that this disease is due to a deficiency of N-acetylglucosaminyltransferase II (GnT II) or alpha-Mannosidase II (alpha-Man II), which represent the key to glycosylation. In addition, a third candidate gene is alpha-Man IIx, which shows a strong homology with alpha-Man II. The knowledge of the chromosomal localization of these putative genes allowed us to perform a linkage study using three sets of microsatellite markers flanking the candidate genes. Six families with two or more affected children were enrolled in this study. The data obtained exclude linkage to all three candidate genes. In consideration of the biochemical data (reduction of enzymatic activity) of the same enzymes, our results suggest the hypothesis that a defect in an unknown transcriptional factor is involved in CDA-II.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9354691

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

Review 1.  Congenital dyserythropoietic anaemias: new acquisitions.

Authors:  Achille Iolascon; Roberta Russo; Maria Rosaria Esposito; Carmelo Piscopo; Roberta Asci; Luigia De Falco; Francesca Di Noce
Journal:  Blood Transfus       Date:  2010-12-13       Impact factor: 3.443

2.  Localization of the gene for congenital dyserythropoietic anemia type I to a <1-cM interval on chromosome 15q15.1-15.3.

Authors:  H Tamary; L Shalmon; H Shalev; A Halil; D Dobrushin; N Ashkenazi; M Zoldan; P Resnitzky; M Korostishevsky; B Bonne-Tamir; R Zaizov
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

3.  Molecular analysis of 42 patients with congenital dyserythropoietic anemia type II: new mutations in the SEC23B gene and a search for a genotype-phenotype relationship.

Authors:  Achille Iolascon; Roberta Russo; Maria Rosaria Esposito; Roberta Asci; Carmelo Piscopo; Silverio Perrotta; Madeleine Fénéant-Thibault; Loïc Garçon; Jean Delaunay
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

4.  Congenital dyserythropoietic anemia type II - a case report of two siblings in a family.

Authors:  Khaidem Ibochouba Singh; Jigme Tenzing Shartsho; Waikhom Ruhini Kumar Singh; Raj Kumari Tamphasana Devi; Ahongshangbam Meina Singh
Journal:  Indian J Hematol Blood Transfus       Date:  2008-03-19       Impact factor: 0.900

Review 5.  The COPII pathway and hematologic disease.

Authors:  Rami Khoriaty; Matthew P Vasievich; David Ginsburg
Journal:  Blood       Date:  2012-05-14       Impact factor: 22.113

Review 6.  Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach.

Authors:  Achille Iolascon; Maria Rosaria Esposito; Roberta Russo
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.